Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: U3-1402
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Collaborators: Daiichi Sankyo